Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for VERU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 1994. Start Trial.
Date Value
September 30, 2025 -30.04M
September 30, 2024 -21.68M
September 30, 2023 -88.01M
September 30, 2022 -47.50M
September 30, 2021 -15.57M
September 30, 2020 -1.930M
September 30, 2019 -5.485M
September 30, 2018 -11.55M
September 30, 2017 0.9829M
September 30, 2016 -1.714M
September 30, 2015 -1.549M
September 30, 2014 3.665M
September 30, 2013 11.79M
September 30, 2012 10.36M
September 30, 2011 6.968M
September 30, 2010 3.992M
Date Value
September 30, 2009 5.747M
September 30, 2008 4.244M
September 30, 2007 -0.042M
September 30, 2006 0.2679M
September 30, 2005 -0.1993M
September 30, 2004 -0.2168M
September 30, 2003 0.29M
September 30, 2002 -0.3787M
September 30, 2001 -0.625M
September 30, 2000 -1.032M
September 30, 1999 -2.841M
September 30, 1998 -2.753M
September 30, 1997 -5.008M
September 30, 1996 -4.072M
September 30, 1995 -4.632M
September 30, 1994 -7.664M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 185.22M
Corcept Therapeutics, Inc. 142.00M
Johnson & Johnson 24.53B
Eli Lilly & Co. 16.81B
Lexicon Pharmaceuticals, Inc. -67.85M